New Diabetes Medicine Poses no Risk to Medical Device Market

The question of whether the need for insulin, and management of blood glucose solutions will keep increasing has been raised by the introduction of new medications that regulate blood sugar and promote weight loss.

Companies that provide devices to deliver the medication may be impacted by a decline in new insulin starts. Despite the fact that “the jury is still out on whether a chasm will present itself,” researchers believe that overall demand for gadgets will continue to rise.

Experts reported that, “Most physicians and companies” believe “that ultimately insulin therapy will not be displaced when patient adherence, difficulty in sustaining lifestyle changes, and side effects are taken into consideration.” While “short-lived pressures could emerge”, this “will likely prove transient to underlying CGM and integrated pump market trajectories.”

According to statistics and other factors, specialists predict that the overall medtech market will grow, which suggests that diabetes will likely continue to be one of the industry’s quickest-developing areas in the future.

© Copyright 2010-2021 Zenopa LTD. All Rights Reserved.